查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965917

血糖值监测试纸市场－全球产业规模、份额、趋势、机会、预测：按类型、最终用户、地区和竞争格局划分，2021-2031年

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球血糖试纸市场预计将从 2025 年的 84.6 亿美元成长到 2031 年的 129.2 亿美元，复合年增长率为 7.31%。

血糖测定器を用いて试薬により糖度を定量化するこれらの诊断用消耗品は、世界の糖尿病の负担増大と慢性ケアを必要とする高齢化人口により需要が拡大しております。国际糖尿病连合のデータによれば、2024年时点で世界中に约5亿8,900万人の成人が糖尿病を患っており、この膨大な患者层が消费を牵引しております。在居家医疗环境において血糖コントロールを维持し併发症を回避するためには、自己管理が依然として极めて重要であるためです。

市场概览
预测期 2027-2031
市场规模：2025年 84.6亿美元
市场规模：2031年 129.2亿美元
复合年增长率：2026-2031年 7.31%
成长最快的细分市场 妊娠糖尿病
最大的市场 北美洲

然而，市场面临着一个重大挑战，消费者越来越倾向于使用无需频繁且痛苦的指尖采血的连续血糖监测系统。这种技术转变对传统血糖试纸的销售构成威胁，因为患者越来越多地采用能够提供即时测量的感测器设备。因此，儘管糖尿病的整体盛行率持续上升，但这些先进替代方案的快速普及可能会阻碍传统检测耗材的收入成长。

市场驱动因素

市场成长的主要驱动力是全球糖尿病盛行率的不断上升。便利且频繁的血糖监测方案对于有效控制疾病至关重要。随着都市化和生活方式的改变加速了第2型糖尿病的发展，维持血糖控制所需的诊断检测量也随着患者数量的增长而相应增加。这一增长的关键因素在于识别出先前未确诊的病例，这使得这些人立即成为检测用品的积极消费者。根据国际糖尿病联盟（IDF）于2025年4月发布的第11版《糖尿病地图集》，目前全球约有2.52亿成年人患有未确诊的糖尿病，随着筛检措施的加强，这代表着一个巨大的潜在市场。

同时，居家自我管理的日益普及正在重新定义患者参与的方式，并推动对诊断耗材的需求。这种向预防医学的转变使患者能够在医疗机构之外主动监测血糖值，从而降低急性併发症和延长住院时间的风险。便捷易用的检测设备的普及也促进了这一趋势，鼓励患者定期检测并持续购买试纸。强劲的市场表现也反映在主要企业的财务表现中。例如，罗氏公司于2025年1月发布的《2024年度报告》显示，其核心诊断业务的销售额成长了8%。国际糖尿病联盟（IDF）也预测，到2025年，全球与糖尿病相关的医疗支出将达到1.015兆美元，凸显了经济高效的管理工具的重要性。

市场挑战

持续血糖监测（CGM）系统的快速普及为传统血糖试纸产业的发展带来了巨大挑战。与每次测量都需要使用专用试纸的标准血糖仪不同，CGM设备采用皮下感测器，可实现24小时即时血糖值监测，从根本上改变了诊断耗材的消费模式。随着使用感测器的患者减少对频繁指尖采血的依赖（试纸主要用于备用或偶尔校准），传统製造商正面临持续且不可逆转的销售量下滑，而这正是他们的主要收入来源。

近期的一些应用指标也印证了这种从传统检测方法转向新型血糖监测技术的转变。根据美国糖尿病协会的数据，到2024年，美国第1型糖尿病患者中，年轻患者使用持续血糖监测技术的比例将达到约47%，成年患者将达到约37%。这种向基于感测器的解决方案的显着转变表明，需要进行最密集血糖监测的用户群体中，相当一部分正在放弃传统的血糖试纸市场。因此，这些先进设备的普及限制了试纸市场的整体潜在规模，并有效地抵消了原本预期因全球糖尿病盛行率上升而带来的收入成长。

市场趋势

以价值为导向的综合糖尿病管理服务的兴起，正在从根本上改变收入结构，推动行业从一次性耗材销售转向全面的订阅模式。製造商正日益将血糖试纸整合到包含远端指导和数据分析的综合套餐中，从而确保长期稳定的收入来源，降低价格下跌的风险。这种方法强调持续的护理互动而非一次性检测，从而提高了患者的依从性。 DarioHealth 于 2025 年 3 月发布的「2024 年第四季及全年财务表现」报告证实了此模式的成功，报告显示其 B2B2C 业务管道的经常性收入达到 560 万美元，年成长 398%。

同时，随着支付者和消费者将降低成本作为首要考虑因素，自有品牌和品牌专卖店的试纸正迅速占据显着的市场份额。由于医疗系统面临糖尿病带来的沉重经济负担，零售环境中高品质、低成本的非专利药正在加速取代传统的高端品牌。这一趋势推动了专注于白牌生产的製造商的销售成长，这些製造商能够在保证准确性的前提下提供价格实惠的产品。这项业绩体现在新康生物感测技术有限公司于2025年4月发布的《2024年度报告》中，这家领先的高性价比生物感测技术製造商累计，其净利润为3.2629亿元人民币（同比增长14.73%）。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球血糖值监测试纸市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（厚电化学膜、薄电化学膜、光学条带）
    • 依最终使用者（医院、门诊手术中心等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美血糖值监测试纸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲血糖值监测试纸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区血糖值监测试纸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲血糖值监测试纸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲血糖值监测试纸市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球血糖值监测试纸市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Abbott Laboratories, Inc
  • Dexcom, Inc
  • F. Hoffmann-La Roche AG
  • Medtronic plc
  • Ascensia Diabetes Care Holdings AG
  • Sinocare Inc
  • Nemaura Medical Inc
  • Nipro Corporation
  • ARKRAY, Inc
  • Senseonics Holdings, Inc
  • B. Braun Medical Inc
  • LifeScan Inc
  • Prodigy Diabetes Care LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20211

The Global Blood Glucose Test Strips Market is projected to expand from a valuation of USD 8.46 Billion in 2025 to USD 12.92 Billion by 2031, reflecting a CAGR of 7.31%. These diagnostic consumables, which utilize reagents to quantify sugar levels through glucometers, are seeing demand fueled by the intensifying global burden of diabetes and an aging population necessitating chronic care. Data from the International Diabetes Federation indicates that approximately 589 million adults were living with diabetes worldwide in 2024, a massive patient demographic that drives consumption as self-monitoring remains critical for maintaining glycemic control and averting complications within home healthcare environments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.46 Billion
Market Size 2031USD 12.92 Billion
CAGR 2026-20317.31%
Fastest Growing SegmentGestational Diabetes
Largest MarketNorth America

However, the market faces a substantial obstacle in the form of growing consumer preference for Continuous Glucose Monitoring systems, which remove the necessity for frequent and painful finger-prick tests. This technological shift poses a risk to traditional strip sales volumes as patients increasingly adopt sensor-based devices that provide real-time metrics. Consequently, the rapid widespread adoption of these sophisticated alternatives has the potential to hinder the revenue growth of conventional testing supplies, even as the overall prevalence of diabetes continues to rise.

Market Driver

The primary catalyst propelling market growth is the escalating global prevalence of diabetes mellitus, which necessitates accessible and frequent glucose monitoring solutions for effective condition management. As urbanization and lifestyle shifts drive the incidence of Type 2 diabetes, the expanding patient pool creates a proportional rise in the diagnostic testing volume needed to sustain glycemic control. A significant driver of this expansion is the identification of previously undiagnosed cases, which immediately transforms individuals into active consumers of testing supplies; according to the 'IDF Diabetes Atlas 11th Edition' released by the International Diabetes Federation in April 2025, nearly 252 million adults globally are currently living with undiagnosed diabetes, representing a vast latent market segment as screening initiatives ramp up.

Concurrently, the increasing adoption of home-based self-monitoring is redefining patient engagement and upholding demand for diagnostic consumables. This pivot toward preventive healthcare empowers patients to actively track blood sugar levels outside of clinical environments, thereby lowering the risks of acute complications and long-term hospitalizations, a trend supported by the proliferation of user-friendly testing devices that encourage regular checks and recurring strip purchases. The market's robustness is reflected in the financial results of major industry players; for instance, Roche's 'Annual Report 2024', published in January 2025, noted an 8% sales increase in its Diagnostics Division's base business, while the International Diabetes Federation estimated in 2025 that diabetes accounted for USD 1.015 trillion in global health expenditure, underscoring the critical need for cost-effective management tools.

Market Challenge

The rapid expansion of Continuous Glucose Monitoring (CGM) systems presents a significant barrier to the growth of the traditional blood glucose test strips sector. In contrast to standard glucometers that demand a specific strip for each reading, CGM devices employ subcutaneous sensors to offer real-time, 24-hour glucose tracking, fundamentally shifting the diagnostic supply consumption model. As patients utilizing sensors reduce their reliance on frequent finger-prick testing-using strips primarily for backup or occasional calibration-the recurring sales volume that serves as the main revenue source for legacy manufacturers faces a direct and irreversible downturn.

Recent adoption metrics substantiate this displacement of conventional testing methods. Data from the American Diabetes Association indicates that in 2024, the utilization of continuous glucose monitoring technology rose to approximately 47% among youth and 37% among adults with type 1 diabetes in the United States. This significant migration toward sensor-based solutions suggests that a substantial fraction of the most intensive glucose monitoring users are departing the daily test strip market. Consequently, the widespread uptake of these advanced devices constrains the total addressable market for strips, effectively neutralizing potential revenue benefits that would otherwise stem from the rising global prevalence of diabetes.

Market Trends

The emergence of value-based bundled diabetes management services is fundamentally reshaping revenue mechanisms, transitioning the industry from transactional consumable sales to holistic subscription models. Manufacturers are increasingly incorporating test strips into comprehensive packages that feature remote coaching and data analytics, thereby securing long-term recurring revenue streams that are less vulnerable to price erosion. This approach improves patient adherence by emphasizing continuous care engagement over isolated testing, a model whose success is highlighted by DarioHealth's 'Fourth Quarter and Full Year 2024 Financial and Operating Results' from March 2025, which reported a 398% year-over-year surge in recurring revenues from its B2B2C business channel to USD 5.6 million.

Simultaneously, the proliferation of private label and store-brand test strips is securing significant market share as payers and consumers prioritize cost containment. With healthcare systems facing the heavy economic weight of diabetes, there is an accelerated migration toward high-quality, lower-cost generic alternatives that are displacing legacy premium brands in retail environments. This trend fuels volume growth for manufacturers focused on white-label production who deliver affordability without sacrificing accuracy, a performance reflected in Sinocare Inc.'s '2024 Annual Report' from April 2025; the company, a key producer of cost-effective biosensing technologies, announced a net income of CNY 326.29 million, representing a 14.73% increase over the previous year.

Key Market Players

  • Abbott Laboratories, Inc
  • Dexcom, Inc
  • F. Hoffmann-La Roche AG
  • Medtronic plc
  • Ascensia Diabetes Care Holdings AG
  • Sinocare Inc
  • Nemaura Medical Inc
  • Nipro Corporation
  • ARKRAY, Inc
  • Senseonics Holdings, Inc
  • B. Braun Medical Inc
  • LifeScan Inc
  • Prodigy Diabetes Care LLC

Report Scope

In this report, the Global Blood Glucose Test Strips Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Glucose Test Strips Market, By Type

  • Thick Film Electrochemical Films
  • Thin Film Electrochemical Films
  • Optical Strips

Blood Glucose Test Strips Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Blood Glucose Test Strips Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Glucose Test Strips Market.

Available Customizations:

Global Blood Glucose Test Strips Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Glucose Test Strips Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips)
    • 5.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Blood Glucose Test Strips Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Glucose Test Strips Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Blood Glucose Test Strips Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Blood Glucose Test Strips Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End-User

7. Europe Blood Glucose Test Strips Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Glucose Test Strips Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Blood Glucose Test Strips Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Blood Glucose Test Strips Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Blood Glucose Test Strips Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Blood Glucose Test Strips Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End-User

8. Asia Pacific Blood Glucose Test Strips Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Glucose Test Strips Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Blood Glucose Test Strips Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Blood Glucose Test Strips Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Blood Glucose Test Strips Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Blood Glucose Test Strips Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Blood Glucose Test Strips Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Glucose Test Strips Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Blood Glucose Test Strips Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Blood Glucose Test Strips Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End-User

10. South America Blood Glucose Test Strips Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Glucose Test Strips Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Blood Glucose Test Strips Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Blood Glucose Test Strips Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Glucose Test Strips Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Dexcom, Inc
  • 15.3. F. Hoffmann-La Roche AG
  • 15.4. Medtronic plc
  • 15.5. Ascensia Diabetes Care Holdings AG
  • 15.6. Sinocare Inc
  • 15.7. Nemaura Medical Inc
  • 15.8. Nipro Corporation
  • 15.9. ARKRAY, Inc
  • 15.10. Senseonics Holdings, Inc
  • 15.11. B. Braun Medical Inc
  • 15.12. LifeScan Inc
  • 15.13. Prodigy Diabetes Care LLC

16. Strategic Recommendations

17. About Us & Disclaimer